Form 4: Bioventus Inc. SVP & CFO Mark Leonard Singleton Reports Acquisition of Restricted Stock Units and Stock Options

Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reports the acquisition of restricted stock units and stock options.

Summary

• On March 15, 2024, Mark Leonard Singleton, the SVP & CFO of Bioventus Inc., reported the acquisition of 80,610 restricted stock units (RSUs), 42,202 RSUs, and 181,980 stock options.
• The RSUs and options vest in installments, contingent on continued service.
• 80,610 RSUs and 181,980 options vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024.
• 42,202 RSUs vest on June 15, 2024.
• The stock options have an exercise price of $5.45 and expire on March 15, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns management with shareholder interests. There are no indications of negative events or concerns.

Positives

• The acquisition of RSUs and stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The vesting schedule of the RSUs and stock options suggests an expectation of continued service by the executive.

Industry Context

This filing is a routine disclosure of insider transactions, common in publicly traded companies to ensure transparency and prevent insider trading.

Stakeholder Impact

• The acquisition of RSUs and stock options by the CFO could positively impact shareholder value by incentivizing strong leadership and aligning management's interests with those of the shareholders.

Key Dates